An observational study investigating and auditing the safety, tolerability and further efficacy characteristics of a pharmaceutical grade cannabis medicine (NanaBis™) prescribed to eligible patients for the management of cancer related or non-cancer related pain in general and specialty medical practices.

Not Applicable

Recruiting

• Conditions: non-cancer related pain; Cancer - Any cancer; Cancer related pain; Anaesthesiology - Pain management

• Registration Number: ACTRN12619000513112
• Lead Sponsor: Medlab Clinical

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-01
• Last Update Posted: 22 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1.Prospective participants greater than or equal to 18 years of age at time of entry on study;
2.Prospective participants have the cognitive ability to understand the informed consent process and to give informed consent to participate in the observational study;
3.Prospective participants have been lawfully prescribed NanaBis™ by their Consenting Doctor;
4.Prospective participants are prescribed NanaBis™ for the management of cancer related or non-cancer related pain;
5.Prospective participants are able to visit the Consenting Doctor as required while administering NanaBis™ and are able to provide information as required to the Consenting Doctor for the duration of the study;
6.Prospective participants agree to abstain from using cannabis products other than NanaBis™ for the duration of their participation in the study.

Exclusion Criteria

1.Prospective participants will be ineligible if they are under the age of 18 years;
2.Prospective participants will be ineligible if they are unwilling or unable to sign the Informed Consent Form or cannot understand the Participant Information Sheet provided;
3.Prospective participants will be ineligible if the Consenting Doctor determines that the prospective participant is unable to fulfill any of the requirements of the study;
4.Prospective participants will be ineligible if they are unwilling or unable to perform study procedures as described in the study protocol.
5. Prospective participants will be ineligible if they are currently using Illicit drugs and/or with alcohol abuse.

Study & Design

• Study Type: Observational
• Study Design: Not specified